Modelled DT Structure
Method: homology modeling
Template PDB: 2LCK_A
Identity: 37.634%
Minimized Score: -412.992 kcal/mol
Detail: Structure Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0168 | ||||
| Gene Name | SLC25A10 | ||||
| Protein Name | Mitochondrial dicarboxylate carrier | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: homology modeling Template PDB: 2LCK_A Identity: 37.634% Minimized Score: -412.992 kcal/mol Detail: Structure Info |
||||
| Synonyms | DIC; SLC25A10; Solute carrier family 25 member 10 | ||||
| DT Family | Mitochondrial Carrier (MC) Family ; | ||||
| Tissue Specificity | Present in high amounts in liver and kidney,and at lower levels in all the other tissues analyzed. | ||||
| Function | This transporter involved in translocation of malonate, malate and succinate in exchange for phosphate, sulfate, sulfite or thiosulfate across mitochondrial inner membrane. | ||||
| Endogenous Substrate(s) | Succinate; Thiosulfate; Malate | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
(ε) Exogenous Modulation of This DT |
|||||
|
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
|
(β) Inter-species Structural Differences |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Phosphate
|
Approved | Drug Info | Constipation | ME05.0 | [1] |
| References | |||||
| 1 | SLC25A10 biallelic mutations in intractable epileptic encephalopathy with complex I deficiency. Hum Mol Genet. 2018 Feb 1;27(3):499-504. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.